December 19, 2016 / 12:30 PM / in 7 months

BRIEF-Novocure's optune approved in Japan for the treatment of newly diagnosed glioblastoma

1 Min Read

Dec 19 (Reuters) - Novocure Ltd

* Novocure Ltd says will prepare to submit an application for public reimbursement of optune for newly diagnosed supra-tentorial glioblastoma in Japan

* Novocure's optune (novottf-100a) approved in Japan for the treatment of newly diagnosed glioblastoma Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below